L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
29,850
-2,450 (-7.59%)
Jul 18, 2025, 3:30 PM KST

L&C BIO Co.,LTD Revenue

L&C BIO Co.,LTD had revenue of 17.76B KRW in the quarter ending March 31, 2025, with 7.41% growth. This brings the company's revenue in the last twelve months to 73.32B, up 8.36% year-over-year. In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B with 9.35% growth.

Revenue (ttm)
73.32B
Revenue Growth
+8.36%
P/S Ratio
10.02
Revenue / Employee
555.44M
Employees
132
Market Cap
734.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202472.09B6.17B9.35%
Dec 31, 202365.93B13.35B25.40%
Dec 31, 202252.57B6.90B15.10%
Dec 31, 202145.68B12.70B38.53%
Dec 31, 202032.97B3.82B13.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
HLB Co., Ltd.74.64B
Peptron4.30B
PharmaResearch392.31B
Revenue Rankings